Request for Covid-19 Impact Assessment of this Report

Take Action
Healthcare

Global Mycoplasma Testing Market Size study, by Product & Services (Reagents & Kits, Instruments, Services), by Technique (Polymerase Chain Reaction (PCR), Elisa, Direct Assays, Indirect Assays, DNA Staining, Others), by Application (Cell Line Testing, Virus Testing, End-of-Production Cell Testing, Others), by End-User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic Research Institutes, Cell Banks, Others) and Regional Forecasts 2020-2026

  • BIZ3837213
  • 200 Pages
  • April 2020
  • Healthcare
Download Sample    Get Discount   
 
Global Mycoplasma Testing Market is valued approximately USD 662 million in 2019 and is anticipated to grow with a healthy growth rate of more than 12.5% over the forecast period 2020-2026. Mycoplasma is referred to as the class of bacteria commonly present in cell culture. It is also known as mollicutes, these bacteria require a cell wall, which make them impervious to frequently use antibiotics, such as penicillin. Mycoplasma is easily spread via droplets throughout cell culture and can persist in dried form for months. Mycoplasma infection is complex to see with a microscope and involves specific testing, to be detected. Infection can have an acute impact on experimental work reliant on the species present. Mycoplasma organisms can affect cell growth, tumorigenicity, metabolism and response to chemotherapy. Rising research activities conducted by pharmaceutical and biotechnology companies, increased government support and funding in research activities, and growing cell culture contamination around the world are the few factors responsible for high CAGR of the market over the forecast period. For instance, in 2018, Boehringer Ingelheim, a pharmaceutical company, has announced its plans to invest almost $259 million for its novel Biologicals Development Center (BDC), to be sited as a R&D hub in Germany. Similarly, Merck KGaA is also planning to invest around $16 billion in R&D over the next five years, in addition to its yearly investment of $7 billion. Therefore, a huge amount of investments in R&D activities, is expected to drive the demand for mycoplasma testing products around the world. However, high degree of consolidation acts and stringent regulatory framework are the few factors expected to hamper the growth of the market over the forecast period of 2020-2026.

The regional analysis of global Mycoplasma Testing market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the expanding healthcare expenditure and rising investments by the U.S. government to enhance research-based activities in biopharmaceutical industries. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2026, due to regulatory policies enacted by healthcare organizations for improving biosafety quality in the countries like China and India.

Major market player included in this report are:

Charles River Laboratories International, Inc.

Merck KGaA

Lonza Group Ltd.

Roche Diagnostics (Division of F. Hoffman-La Roche Ltd.)

Thermo Fisher Scientific Inc.

American Type Culture Collection

Biounique Testing Laboratories Inc.

Invivogen

Promocell GmbH

Biological Industries Israel Beit Haemek Ltd.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product & Services:

Reagents & Kits

Instruments

Services & Software

By Technique:

Polymerase Chain Reaction (PCR)

Elisa

Direct Assays

Indirect Assays

DNA Staining

Others

By Application:

Cell Line Testing

Virus Testing

End-of-Production Cell Testing

Others

By End-User:

Pharmaceutical and Biotechnology Companies

Contract Research Organizations

Academic Research Institutes

Cell Banks

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

Asia Pacific

China

India

Japan

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2016, 2017, 2018

Base year – 2019

Forecast period – 2020 to 2026

Target Audience of the Global Mycoplasma Testing Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

1.1. Market Snapshot

1.2. Global & Segmental Market Estimates & Forecasts, 2018-2026 (USD Million)

1.2.1. Mycoplasma Testing Market, by Region, 2018-2026 (USD Million)

1.2.2. Mycoplasma Testing Market, by Product & Services, 2018-2026 (USD Million)

1.2.3. Mycoplasma Testing Market, by Technique, 2018-2026 (USD Million)

1.2.4. Mycoplasma Testing Market, by Application, 2018-2026 (USD Million)

1.2.5. Mycoplasma Testing Market, by End-User, 2018-2026 (USD Million)

1.3. Key Trends

1.4. Estimation Methodology

1.5. Research Assumption

Chapter 2. Global Mycoplasma Testing Market Definition and Scope

2.1. Objective of the Study

2.2. Market Definition & Scope

2.2.1. Scope of the Study

2.2.2. Industry Evolution

2.3. Years Considered for the Study

2.4. Currency Conversion Rates

Chapter 3. Global Mycoplasma Testing Market Dynamics

3.1. Mycoplasma Testing Market Impact Analysis (2018-2026)

3.1.1. Market Drivers

3.1.2. Market Challenges

3.1.3. Market Opportunities

Chapter 4. Global Mycoplasma Testing Market Industry Analysis

4.1. Porter’s 5 Force Model

4.1.1. Bargaining Power of Suppliers

4.1.2. Bargaining Power of Buyers

4.1.3. Threat of New Entrants

4.1.4. Threat of Substitutes

4.1.5. Competitive Rivalry

4.1.6. Futuristic Approach to Porter’s 5 Force Model (2016-2026)

4.2. PEST Analysis

4.2.1. Political

4.2.2. Economical

4.2.3. Social

4.2.4. Technological

4.3. Investment Adoption Model

4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Mycoplasma Testing Market, by Product & Services

5.1. Market Snapshot

5.2. Global Mycoplasma Testing Market by Product & Services, Performance - Potential Analysis

5.3. Global Mycoplasma Testing Market Estimates & Forecasts by Product & Services 2016-2026 (USD Million)

5.4. Mycoplasma Testing Market, Sub Segment Analysis

5.4.1. Reagents & Kits

5.4.2. Instruments

5.4.3. Services

Chapter 6. Global Mycoplasma Testing Market, by Technique

6.1. Market Snapshot

6.2. Global Mycoplasma Testing Market by Technique, Performance - Potential Analysis

6.3. Global Mycoplasma Testing Market Estimates & Forecasts by Technique 2016-2026 (USD Million)

6.4. Mycoplasma Testing Market, Sub Segment Analysis

6.4.1. Polymerase Chain Reaction (PCR)

6.4.2. Elisa

6.4.3. Direct Assays

6.4.4. Indirect Assays

6.4.5. DNA Staining

6.4.6. Others

Chapter 7. Global Mycoplasma Testing Market, by Application

7.1. Market Snapshot

7.2. Global Mycoplasma Testing Market by Application, Performance - Potential Analysis

7.3. Global Mycoplasma Testing Market Estimates & Forecasts by Application 2016-2026 (USD Million)

7.4. Mycoplasma Testing Market, Sub Segment Analysis

7.4.1. Cell Line Testing

7.4.2. Virus Testing

7.4.3. End-of-Production Cell Testing

7.4.4. Others

Chapter 8. Global Mycoplasma Testing Market, by End-User

8.1. Market Snapshot

8.2. Global Mycoplasma Testing Market by End-User, Performance - Potential Analysis

8.3. Global Mycoplasma Testing Market Estimates & Forecasts by End-User 2016-2026 (USD Million)

8.4. Mycoplasma Testing Market, Sub Segment Analysis

8.4.1. Pharmaceutical and Biotechnology Companies

8.4.2. Contract Research Organizations

8.4.3. Academic Research Institutes

8.4.4. Cell Banks

8.4.5. Others

Chapter 9. Global Mycoplasma Testing Market, Regional Analysis

9.1. Mycoplasma Testing Market, Regional Market Snapshot

9.2. North America Mycoplasma Testing Market

9.2.1. U.S. Mycoplasma Testing Market

9.2.1.1. Product & Services breakdown estimates & forecasts, 2016-2026

9.2.1.2. Technique breakdown estimates & forecasts, 2016-2026

9.2.1.3. Application breakdown estimates & forecasts, 2016-2026

9.2.1.4. End-User breakdown estimates & forecasts, 2016-2026

9.2.2. Canada Mycoplasma Testing Market

9.3. Europe Mycoplasma Testing Market Snapshot

9.3.1. U.K. Mycoplasma Testing Market

9.3.2. Germany Mycoplasma Testing Market

9.3.3. Rest of Europe Mycoplasma Testing Market

9.4. Asia-Pacific Mycoplasma Testing Market Snapshot

9.4.1. China Mycoplasma Testing Market

9.4.2. India Mycoplasma Testing Market

9.4.3. Japan Mycoplasma Testing Market

9.4.4. Rest of Asia Pacific Mycoplasma Testing Market

9.5. Latin America Mycoplasma Testing Market Snapshot

9.5.1. Brazil Mycoplasma Testing Market

9.5.2. Mexico Mycoplasma Testing Market

9.6. Rest of The World Mycoplasma Testing Market

Chapter 10. Competitive Intelligence

10.1. Top Market Strategies

10.2. Company Profiles

10.2.1. Charles River Laboratories International, Inc.

10.2.1.1. Key Information

10.2.1.2. Overview

10.2.1.3. Financial (Subject to Data Availability)

10.2.1.4. Product Summary

10.2.1.5. Recent Developments

10.2.2. Merck KGaA

10.2.3. Lonza Group Ltd.

10.2.4. Roche Diagnostics (Division of F. Hoffman-La Roche Ltd.)

10.2.5. Thermo Fisher Scientific Inc.

10.2.6. American Type Culture Collection

10.2.7. Biounique Testing Laboratories Inc.

10.2.8. Invivogen

10.2.9. Promocell GmbH

10.2.10. Biological Industries Israel Beit Haemek Ltd.

Chapter 11. Research Process

11.1. Research Process

11.1.1. Data Mining

11.1.2. Analysis

11.1.3. Market Estimation

11.1.4. Validation

11.1.5. Publishing

11.2. Research Attributes

11.3. Research Assumption

List of Tables

TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL MYCOPLASMA TESTING MARKET

TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL MYCOPLASMA TESTING MARKET

TABLE 3. GLOBAL MYCOPLASMA TESTING MARKET, REPORT SCOPE

TABLE 4. YEARS CONSIDERED FOR THE STUDY

TABLE 5. EXCHANGE RATES CONSIDERED

TABLE 6. GLOBAL MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD MILLION)

TABLE 7. GLOBAL MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY PRODUCT & SERVICES 2016-2026 (USD MILLION)

TABLE 8. GLOBAL MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY TECHNIQUE 2016-2026 (USD MILLION)

TABLE 9. GLOBAL MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY APPLICATION 2016-2026 (USD MILLION)

TABLE 10. GLOBAL MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY END-USER 2016-2026 (USD MILLION)

TABLE 11. GLOBAL MYCOPLASMA TESTING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 12. GLOBAL MYCOPLASMA TESTING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 13. GLOBAL MYCOPLASMA TESTING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 14. GLOBAL MYCOPLASMA TESTING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 15. GLOBAL MYCOPLASMA TESTING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 16. GLOBAL MYCOPLASMA TESTING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 17. GLOBAL MYCOPLASMA TESTING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 18. GLOBAL MYCOPLASMA TESTING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 19. GLOBAL MYCOPLASMA TESTING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 20. GLOBAL MYCOPLASMA TESTING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 21. U.S. MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 22. U.S. MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 23. U.S. MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 24. CANADA MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 25. CANADA MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 26. CANADA MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 27. UK MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 28. UK MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 29. UK MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 30. GERMANY MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 31. GERMANY MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 32. GERMANY MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 33. ROE MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 34. ROE MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 35. ROE MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 36. CHINA MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 37. CHINA MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 38. CHINA MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 39. INDIA MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 40. INDIA MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 41. INDIA MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 42. JAPAN MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 43. JAPAN MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 44. JAPAN MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 45. ROAPAC MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 46. ROAPAC MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 47. ROAPAC MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 48. BRAZIL MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 49. BRAZIL MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 50. BRAZIL MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 51. MEXICO MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 52. MEXICO MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 53. MEXICO MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 54. ROLA MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 55. ROLA MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 56. ROLA MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 57. ROW MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 58. ROW MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 59. ROW MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

2020 World Blood Typing, Grouping and Infectious Disease NAT Screening Market in 68 Countries: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for over 40 Tests, Technology and Instrumentation Review

This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.

The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...

  • Publish Date: March 2, 2020
  • $0
View Details
Hearing Aids Market in India 2011

Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...

  • Publish Date: March 10, 2011
  • $950
View Details
Cardiac Pacemaker Market in India 2011

The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...

  • Publish Date: July 18, 2011
  • $950
View Details
 
View More
 

Client Testimonials

2025 © Copyright Big Market Research